Physician profile
Alphonse Pecoraro
NPI 1568485852
$14,968.14
in general payments reported to CMS, 2019-2025
22 companies · $465 in 2025
The $465 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,470 · 2020: $48.36 · 2021: $4,409 · 2022: $53.97 · 2023: $3,918 · 2024: $604 · 2025: $465.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $2,164 · Travel and Lodging: $1,803 · Food and Beverage: $1,020.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $2,163.93 |
| Travel and Lodging | $1,803.19 |
| Food and Beverage | $1,020.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $13,013.43 | 2019-2025 | Davinci Xi, Da Vinci Surgical System |
| Inspire Medical Systems, INC. | $888.74 | 2023-2025 | Inspire |
| Conmed Corporation | $155.83 | 2019-2021 | |
| Vertex Pharmaceuticals Incorporated | $143.78 | 2024-2025 | |
| Abbott Laboratories | $136.25 | 2023-2025 | Freestyle Libre 3 |
| Genentech USA, INC. | $111.37 | 2019 | |
| Ethicon US, LLC | $98.61 | 2025 | Vistaseal, Stratafix |
| Next Science LLC | $58.54 | 2021-2023 | Xperience, Blastx, Surgx |
| Organogenesis INC. | $47.98 | 2019-2020 | |
| Lilly USA, LLC | $44.48 | 2023-2024 | Mounjaro |
| Medtronic, INC. | $41.06 | 2023-2024 | Progrip, Closurefast |
| Smith+Nephew, INC. | $39.38 | 2019-2021 | |
| Glaxosmithkline, LLC. | $25.40 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $24.73 | 2025 | Iclusig |
| Hologic Sales and Service, LLC | $23.32 | 2023 | Coolseal Generator |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Caris Mpi, INC. | $19.84 | 2025 | Mi Cancer Seek |
| Merck Sharp & Dohme LLC | $18.20 | 2023 | Bridion |
| Argenx US, INC. | $16.62 | 2024 | Vyvgart, Vyvgart Hytrulo |
| Kci USA, INC. | $16.41 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $16.17 | 2025 | Exparel |
| Guard Medical INC. | $14.05 | 2024 | Npseal Large |
| Tactile Systems Technology INC | $13.95 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alphonse Pecoraro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.